Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biogen Pharmachem Industries Limited has issued a Postal Ballot Notice to shareholders seeking approval for three resolutions by remote e-voting. The first resolution proposes a bonus issue in the ratio of 1:6, i.e., 1 new equity share of Rs. 1 each for every 6 existing shares, by capitalizing Rs. 17 crore from the Share Premium Account as on March 31, 2025. The second resolution seeks to increase the authorised share capital from Rs. 91 crore to Rs. 108 crore (creating an additional 17 crore equity shares of Rs. 1 each) and amend Clause V of the Memorandum of Association to accommodate the bonus issue. The third resolution is to appoint M/s. Goenka Mehta & Associates, Chartered Accountants, Rajkot (FRN: 129445W) as statutory auditor to fill the casual vacancy arising from the resignation of M/s. Rishi Sekhri & Associates due to significant medical conditions. E-voting runs from 9:00 AM on March 27, 2026 to 5:00 PM on April 25, 2026, with results to be declared on or before April 27, 2026.
If approved, eligible shareholders will receive 1 additional share for every 6 held, increasing share count without a corresponding change in underlying value, funded entirely from share premium reserves. The authorised capital expansion and auditor replacement are procedural steps to support the bonus issue and maintain compliance, with no negative signals for shareholders.